Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

Sonia Pernas, Miguel Martin, Peter A. Kaufman, Marta Gil-Martin, Patricia Gomez Pardo, Sara Lopez-Tarruella, Luis Manso, Eva Ciruelos, Jose Alejandro Perez-Fidalgo, Cristina Hernando, Foluso O. Ademuyiwa, Katherine Weilbaecher, Ingrid Mayer, Timothy J. Pluard, Maria Martinez Garcia, Linda Vahdat, Jose Perez-Garcia, Achim Wach, Debra Barker, Samson FungBarbara Romagnoli, Javier Cortes

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial'. Together they form a unique fingerprint.

Medicine & Life Sciences